Biotechnology - Techseriesinsight

June 26, 2025
PRNewswire
Biotechnology, Healthcare, News

Cellarity Starts Phase 1 Trial of CLY-124 for Sickle Cell

Cellarity, a biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced that the first subject has been dosed in a Phase 1 clinical trial...

Bit Digital Shifts Entire Treasury to Ethereum

June 25, 2025
PRNewswire
Biotechnology, News

Urve Therapeutics’ Ali Tavassoli Wins Prestigious RSC Interdisciplinary Prize

Curve Therapeutics (“Curve” or the “Company”), a private biotechnology company building a pipeline of innovative cyclic peptide and small molecule drugs to address high priority intracellular disease targets, today...

June 25, 2025
PRNewswire
Biotechnology, News

EDAN Expands Americas Presence with New Subsidiary in Mexico

EDAN Instruments, Inc. (300206.SZ), a healthcare company and medical device manufacturer, officially celebrated the opening of its new subsidiary, EDAN MEDICAL MÉXICO S de R.L. de C.V., with a...

June 25, 2025
Business Wire
Biotechnology, Healthcare, News

Takeda Announces New Assignments of Directors

Takeda (TOKYO:4502/NYSE:TAK) has announced new assignments of directors, determined at the Board of Directors meeting, following the 149th Annual Meeting of Shareholders, held in Osaka today. Takeda’s Board of...

June 24, 2025
PRNewswire
Biotechnology, Healthcare, News

Bio-Techne and USP Drive Breakthroughs in Antibody and Gene Therapies

Bio-Techne Corporation (NASDAQ: TECH) today announced a distribution agreement with the U.S. Pharmacopeia (USP) that enables the Company to sell USP monoclonal antibody (mAb) and recombinant adeno-associated virus (AAV) reference...

June 24, 2025
PRNewswire
Biotechnology, Healthcare, News

Pharmactive’s Saffron Extract Proven to Boost Mood and Emotional Wellness

Results from a new, large-scale clinical study demonstrate Pharmactive Biotech Products, S.L.U.’s flagship saffron extract Affron could help lift the mood in people suffering from mild depressive symptoms. Building on ten previous...

June 23, 2025
PRNewswire
Biotechnology, Healthcare, News

Cell Study by SDU and PKU Researchers Reveals Novel Mechanism to Regulate Glucose Metabolism

On May 29, 2025, Professor Sun Jinpeng’s team and Professor Yu Xiao’s team at Shandong University, collaborating with Professor Jiang Changtao from Peking University, Professor Pang Yanli, and Professor Ji Linong, published a research paper entitled “A microbial...

June 23, 2025
PRNewswire
Biotechnology, News

Leap Therapeutics Reports Updated Clinical Data from Sirexatamab Colorectal Cancer Study and Announces Exploration of Strategic Alternatives

A biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported updated results from Part B of the DeFianCe study (NCT05480306), a Phase 2 study of sirexatamab (DKN-01),...

June 20, 2025
PRNewswire
Biotechnology, News

IONETIX Corporation and AlfaRim Medical B.V. announce a strategic partnership to fast-track commercial production of Actinium-225

IONETIX, a leading cyclotron technology innovator and full-service isotope manufacturer, and AlfaRim, a Dutch deeptech company pioneering industrial-scale production of cGMP-grade Actinium-225, today announced a strategic collaboration to commercialize...

June 20, 2025
PRNewswire
Biotechnology, News

Neurocrine Biosciences Presents New Data Showing Significant Patient-Reported Improvements in Health-Related Quality of Life with INGREZZA® (valbenazine) Capsules in Older Adults with Tardive Dyskinesia

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the presentation of new analyses from a Phase 4 randomized withdrawal study demonstrating significant patient-reported improvements in health-related quality of life and functional measures among...